Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2021-04-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
2020年度独立董事述职报告（林琳）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for the year 2020" from a company. It details the independent director's attendance at board and shareholder meetings, opinions on various company matters including use of funds, stock repurchases, internal controls, appointment of financial officers, and non-public stock issuance. It also discusses supervision of governance, protection of investor rights, and committee work. The content is a detailed report on the independent director's duties and opinions over the year, not a general annual report or earnings release. It is not a simple announcement or certification but a substantive report on governance and oversight activities by the independent director. This fits best with the category of Board/Management Information (MANG), which includes announcements or reports related to board or senior management activities and changes. The document is not an annual report (10-K), audit report (AR), or proxy solicitation (PSI), but a detailed independent director report on governance and oversight for the year. Confidence is high given the detailed nature and focus on board activities and independent director opinions.
2021-04-26 Chinese
年度股东大会通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2020 Annual General Meeting (AGM) of the company, including the date, time, venue, agenda items, voting procedures, and related attachments such as proxy forms and voting instructions. It does not contain the actual annual report or financial statements but rather the announcement and procedural information for the AGM. The document length is about 5557 characters, which is consistent with a detailed meeting notice rather than a full annual report. Therefore, this document fits the category of AGM Information (AGM-R).
2021-04-26 Chinese
关于续聘2020年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the audit firm Tianjian Certified Public Accountants for the 2021 fiscal year. It details the audit firm's qualifications, past performance, independence, and the approval process by the board and supervisory committee. It does not contain actual audited financial statements or detailed audit reports but rather serves as a formal notice of the audit firm's continued engagement. The document length is 3596 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits the category of an Audit Report / Information announcement about the audit firm appointment rather than the audit report itself. Hence, the appropriate classification is AR (Audit Report / Information). FY 2021
2021-04-26 Chinese
2020年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled "2020 年度审计报告" which translates to "2020 Annual Audit Report". It contains detailed audit opinions, financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes to the financial statements. The document is lengthy (15,000 characters) and includes comprehensive financial data and audit procedures. The presence of an auditor's opinion, detailed financial statements, and notes indicates this is a standalone audit report rather than a full annual report or an announcement. Therefore, the document fits the category of an Audit Report / Information (AR). FY 2020
2021-04-26 Chinese
内部控制规则落实自查表
Audit Report / Information Classification · 95% confidence The document is an internal control self-assessment checklist for a company, detailing the implementation of internal control rules across various areas such as internal audit, information disclosure, insider trading controls, fundraising, related party transactions, guarantees, major investments, and other important matters. It does not contain financial statements, earnings data, or regulatory announcements. It is not a report of audit results, nor a financial report like an annual or interim report. It is also not a certification or a brief announcement. The content focuses on internal control procedures and compliance, which aligns with internal audit or audit-related information. Given the detailed internal control and audit committee operation information, this document fits best under Audit Report / Information (AR). The document length is 3450 characters, which is relatively short but contains substantive internal control audit content rather than just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2020
2021-04-26 Chinese
关于开展2021年度外汇衍生品交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by the company about its plan to conduct foreign exchange derivative transactions in 2021. It includes details about the purpose, scope, risk analysis, risk control measures, and independent directors' opinions. The document is relatively short (1815 characters) and does not contain any financial statements or substantive financial data. It is a regulatory announcement about a specific business activity and requires shareholder approval. There is no indication that this is a full financial report, audit report, or earnings release. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about the company's planned foreign exchange derivative transactions and related governance matters.
2021-04-26 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.